AntibioticDB

TBAJ-876

Diarylquinoline

TB Alliance

2019

Highest development stage: Phase 1
Mechanism of Action/Target pathogen: Anti-mycobacterial drug. Effective against Mycobacterium abscessus and Mycobacterium tuberculosis
GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13132
Source: https://aac.asm.org/content/64/4/e02404-19
Citation (1): https://aac.asm.org/content/64/2/e01540-19
Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/155510360